DOI: https://dx.doi.org/10.18565/therapy.2023.10.108-113
Didigova R.T., Malsagova I.Ya., Buzurtanova M.B., Ugurchieva P.O., Magomaeva Kh.V., Teboeva M.B.
1) Ingush State University, Magas; 2) A.O. Akhushkov Ingush Republican Clinical Hospital, Nazran
1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24): 6735–40. 2. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ. 2004; 157: 301–10. 3. Graham D.Y., Rugge M., Genta R.M. Diagnosis: Gastric intestinal metaplasia – what to do next? Curr Opin Gastroenterol. 2019; 35(6): 535–43. https://dx.doi.org/10.1097/MOG.0000000000000576. 4. Kato I., Tominaga S., Ito Y. et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res. 1992; 83(11): 1137–42. https://dx.doi.org/10.1111/j.1349-7006.1992.tb02736.x. 5. Mera R.M., Bravo L.E., Camargo M.C. et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial. Gut. 2018; 67(7): 1239–46.https://dx.doi.org/10.1136/gutjnl-2016-311685. 6. Ливзан М.А., Гаус О.В., Мозговой С.И. Хронический атрофический гастрит: тактика курации пациента. РМЖ. Медицинское обозрение. 2021; 5(6): 427–432. [Livzan M.A., Gaus O.V., Mozgovoi S.I. Chronic atrophic gastritis: Patient management. Russkiy meditsinskiy zhurnal. Meditsinskoye obozreniye = Russian Medical Journal. Medical Review. 2021; 5(6): 427–432 (In Russ.)].https://dx.doi.org/10.32364/2587-6821-2021-5-6-427-432. EDN: UAXHUG. 7. Ивашкин В.Т., Маев И.В., Лапина Т.Л. с соавт. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018; 28(1): 55–70. Ivashkin V.T., Mayev I.V., Lapina T.L. et al. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian Gastroenterological Association. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28(1): 55–70 (In Russ.)].https://dx.doi.org/10.22416/1382-4376-2018-28-1-55-70. EDN: YRHTSM. 8. Бордин Д.С., Ливзан М.А. Консенсус Маастрихт VI опубликован: что нового? Эффективная фармакотерапия. 2022; 18(22): 72–85. [Bordin D.S., Livzan M.A. The consensus Maastricht VI is published: What’s new? Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2022; 18(22): 72–85 (In Russ.)]. https://dx.doi.org/10.33978/2307-3586-2022-18-22-72-84. EDN: ZEVYNS. 9. Kamada T., Sato M., Tokutomi T. et al. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: A multicenter study. Biomed Res Int. 2015; 2015: 865146. https://dx.doi.org/10.1155/2015/865146. 10. Seo G.H., Lee H. Chemopreventive effect of rebamipide against gastric cancer in patients who undergo endoscopic resection for early gastric neoplasms: A nationwide claims study. Digestion. 2019; 100(4): 221–28. https://dx.doi.org/10.1159/000495288. 11. Pimentel-Nunes P., Libanio D., Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019; 51(4): 365–88. https://dx.doi.org/10.1055/a-0859-1883. 12. Lenti M.V., Rugge M., Lahner E. et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020; 6(1): 56.https://dx.doi.org/10.1038/s41572-020-0187-8. 13. Драпкина О.М., Дроздова Л.Ю., Авдеев С.Н. с соавт. Оказание амбулаторно-поликлинической медицинской помощи пациентам с хроническими заболеваниями, подлежащим диспансерному наблюдению, в условиях пандемии COVID-19. Временные методические рекомендации. Версия 2. Кардиоваскулярная терапия и профилактика. 2021; 20(8): 245–290. [Drapkina O.M., Drozdova L.Yu., Avdeev S.N. et al. The outpatient medical care in patients with chronic diseases under dispensary supervision in the conditions of the COVID-19 pandemic. Temporary guidelines. Version 2. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2021; 20(8): 245–290 (In Russ.)]. https://dx.doi.org/10.15829/1728-8800-2021-3172. EDN: SRCERD.
Rosa T. Didigova, MD, professor, head of the Department of hospital therapy, Ingush State University. Address: 386001, Magas, 7 I.B. Zyazikova Avenue.
E-mail: roza2007@mail.ru
Inna Ya. Malsagova, PhD in Medical Sciences, associate professor of the Department of hospital therapy, Ingush State University. Address: 386001, Magas, 7 I.B. Zyazikova Avenue
Milana B. Buzurtanova, senior lecturer at the Department of hospital therapy, Ingush State University. Address: 386001, Magas, 7 I.B. Zyazikova Avenue
Pyatimat O. Ugurchieva, senior lecturer at the Department of hospital therapy, Ingush State University. Address: 386001, Magas, 7 I.B. Zyazikova Avenue
Khava V. Magomaeva, therapist at A.O. Akhushkov Ingush Republican Clinical Hospital. Address: 386106, Nazran, 11 Kh.B. Mutalieva St.
Malika B. Teboeva, 6th year student of the Faculty of general medicine, Ingush State University. Address: 386001, Magas, 7 I.B. Zyazikova Avenue